Trials / Conditions / CHEK2 Gene Mutation

CHEK2 Gene Mutation

9 registered clinical trials studyying CHEK2 Gene Mutation — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at Hi NCT07499999	Dana-Farber Cancer Institute	Phase 2
Withdrawn	Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alter NCT06392841	Qian Qin	Phase 2
Active Not Recruiting	Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion NCT06033092	European Institute of Oncology	Phase 2
Recruiting	Video Capsule Examination in Patients With Lynch Syndrome NCT06712095	Royal Marsden NHS Foundation Trust	N/A
Recruiting	An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk a NCT05420064	Memorial Sloan Kettering Cancer Center	N/A
Active Not Recruiting	Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response NCT04030559	Marc Dall'Era, MD	Phase 2
Active Not Recruiting	Olaparib In Metastatic Breast Cancer NCT03344965	Beth Israel Deaconess Medical Center	Phase 2
Completed	Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer NCT03377556	SWOG Cancer Research Network	Phase 2
Recruiting	The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. NCT05097274	Institute of Cancer Research, United Kingdom	—